Hereditary onset of multiple seborrheic keratoses: A variant of leser Trélat sign?

Journal of Dermatology

Volumn 23, Issue 3, 1996, Pages 191-195

  Yamamoto, Toshiyuki ^a   Yokoyama, Akiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

familial occurrence; Leser Tr lat sign; multiple seborrheic keratoses; viceral cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN;

AGED; ARTICLE; BILIARY TRACT CANCER; CASE REPORT; CELL PROLIFERATION; DIAGNOSTIC VALUE; ENDOSCOPY; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; SEBORRHEIC KERATOSIS; SYMPTOMATOLOGY;

ADENOCARCINOMA; AGED; BILIARY TRACT NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, SEBORRHEIC; MALE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 0029978165     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb03996.x     Document Type: Article

References (19)

1. Venencie PY, Perry HO,: Sign of Leser-Trélat: Report of two cases and review of the literature, J Am Acad Dermatol, 10: 83-88, 1984.
2. Poole S, Fenske NA,: Cutaneous markers of internal malignancy. II. Paraneoplastic dermatoses and environmental carcinogens, J Am Acad Dermatol, 28: 147-164, 1993.
3. Rheinwald JG, Green H,: Epidermal growth factor and the multiplication of cultured human keratinocytes, Nature, 265: 421-424, 1977.
4. Brown GL, Nanney LB, Griffen J, et al. Enhancement of wound healing by topical treatment with epidermal growth factor, E Engl J Med, 321: 76-79, 1989.
5. Gill GN, Bertics PJ, Santon JB,: Epidermal growth factor and its receptor, Mol Cell Endocrinol, 51: 169-186, 1987.
6. Derynck R,: Transforming growth factor alpha, Cell, 54: 593-595, 1988.
7. Coffey RJ, Derynck R, Wilcox JN, et al. Production and auto-induction of transforming growth factor-alpha in human keratinocytes, Nature, 328: 817-820, 1987.
8. Groves RW, Allen MH, MacDonald DM,: Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours, J Cutan Pathol, 19: 66-72, 1992.
9. Schechter AL, Hung M-C, Vaidyanathan L, et al. The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor, Science, 229: 976-978, 1985.
10. Bargmann CI, Hung M-C, Weinberg RA,: The neu oncogene encodes an epidermal growth factor receptor-related protein, Nature, 319: 226-230, 1986.
11. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, MaGuire WL,: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncongene, Science, 235: 177-182, 1987.
12. Slamon DJ, Godolphin W, Jones LA, et al. Study of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, 244: 707-712, 1989.
13. Van De Vijver MJ, Peterse JL, Mooi WJ, et al. Neu- protein overexpression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage of breast cancer, N Engl J Med, 319: 1239-1245, 1988.
14. Paik S, Hazan R, Fisher ER, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of erbB-2 protein overexpression in primary breast cancer, J Clin Oncol, 8: 103-112, 1990.
15. Lee EY, Cibull ML, Strodel WE, Haley JV,: Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastic carcinoma, Acta Pathol Lab Med, 118: 235-239, 1994.
16. Pinkus H,: Factors involves in skin carcinogenesis. J Am Acad Dermatol, 1: 267-275, 1979.
17. Politi Y, Ophir J, Brenner S,: Cutaneous paraneoplastic syndromes, Acta Derm Venereol (Stockh), 73: 161-170, 1993.
18. Cohen PR,: Cutaneous paraneoplastic syndromes and genodermatoses with malignant potential, Acta Derm Venereol (Stockh), 74: 229, 1994.
19. Yamamoto T, Katayama I, Nishioka K,: Possible role of interleukin-8 in induction of psoriasis-like lesion in Muir-Torre syndrome, Acta Derm Venereol (Stockh). (in press)